{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:51:51Z","timestamp":1787161911116,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00203-025-04314-2","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T15:18:41Z","timestamp":1743779921000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Determining the effect of a new truncated CecropinA-Magenin2 (CE-MA) hybrid peptide on the expression of multidrug-resistant (MDR) Mycobacterium tuberculosis efflux genes"],"prefix":"10.1007","volume":"207","author":[{"given":"Mozhgan","family":"Raigani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soroush","family":"Sardari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzam","family":"Vaziri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Ghajavand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansour","family":"Kargarpour Kamakoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mobina","family":"Majidian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Mazhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6527-7321","authenticated-orcid":false,"given":"Hamid","family":"Madanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"4314_CR12","doi-asserted-by":"crossref","unstructured":"Allu\u00e9-Guardia A, Garc\u00eda JI, Torrelles JB (2021) Evolution of Drug-Resistant Mycobacterium tuberculosis strains and their adaptation to the human lung environment. Front Microbiol.;12","DOI":"10.3389\/fmicb.2021.612675"},{"key":"4314_CR9","doi-asserted-by":"crossref","unstructured":"Alsayed SSR, Gunosewoyo H, Tuberculosis (2023) Pathogenesis, current treatment regimens and new drug targets. Int J Mol Sci.;24(6)","DOI":"10.3390\/ijms24065202"},{"key":"4314_CR28","doi-asserted-by":"crossref","unstructured":"Coelho T, Machado D, Couto I, Maschmann R, Ramos D, von Groll A et al (2015) Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant Mycobacterium tuberculosis clinical isolates from Brazil. Front Microbiol.;6","DOI":"10.3389\/fmicb.2015.00330"},{"issue":"1","key":"4314_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1574-695X.2011.00831.x","volume":"63","author":"PE da Silva","year":"2011","unstructured":"da Silva PE, Von Groll A, Martin A, Palomino JC (2011) Efflux as a mechanism for drug resistance in Mycobacterium tuberculosis. FEMS Immunol Med Microbiol 63(1):1\u20139","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"9","key":"4314_CR30","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41579-018-0048-6","volume":"16","author":"D Du","year":"2018","unstructured":"Du D, Wang-Kan X, Neuberger A, van Veen HW, Pos KM, Piddock LJV et al (2018) Multidrug efflux pumps: structure, function and regulation. Nat Rev Microbiol 16(9):523\u2013539","journal-title":"Nat Rev Microbiol"},{"key":"4314_CR17","doi-asserted-by":"crossref","unstructured":"Fanelli G, Pasqua M, Colonna B, Prosseda G, Grossi M (2020) Expression profile of multidrug resistance efflux pumps during intracellular life of Adherent-Invasive Escherichia coli strain LF82. Front Microbiol.;11","DOI":"10.3389\/fmicb.2020.01935"},{"key":"4314_CR7","doi-asserted-by":"publisher","first-page":"114008","DOI":"10.1016\/j.addr.2021.114008","volume":"179","author":"X Gao","year":"2021","unstructured":"Gao X, Ding J, Liao C, Xu J, Liu X, Lu W (2021) Defensins: the natural peptide antibiotic. Adv Drug Deliv Rev 179:114008","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"4314_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13756-019-0516-4","volume":"8","author":"H Ghajavand","year":"2019","unstructured":"Ghajavand H, Kargarpour Kamakoli M, Khanipour S, Pourazar Dizaji S, Masoumi M, Rahimi Jamnani F et al (2019) Scrutinizing the drug resistance mechanism of multi- and extensively-drug resistant Mycobacterium tuberculosis: mutations versus efflux pumps. Antimicrob Resist Infect Control 8(1):70","journal-title":"Antimicrob Resist Infect Control"},{"key":"4314_CR6","doi-asserted-by":"publisher","first-page":"582779","DOI":"10.3389\/fmicb.2020.582779","volume":"11","author":"Y Huan","year":"2020","unstructured":"Huan Y, Kong Q, Mou H, Yi H (2020) Antimicrobial peptides: classification, design, application and research progress in multiple fields. Front Microbiol 11:582779","journal-title":"Front Microbiol"},{"key":"4314_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejbt.2020.12.006","volume":"50","author":"R Jiang","year":"2021","unstructured":"Jiang R, Zhang P, Wu X, Wang Y, Rehman T, Yao X et al (2021) Expression of antimicrobial peptide cecropin P1 in Saccharomyces cerevisiae and its antibacterial and antiviral activity in vitro. Electron J Biotechnol 50:16\u201322","journal-title":"Electron J Biotechnol"},{"key":"4314_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jgar.2019.01.003","volume":"17","author":"J Kardan-Yamchi","year":"2019","unstructured":"Kardan-Yamchi J, Kazemian H, Haeili M, Harati AA, Amini S, Feizabadi MM (2019a) Expression analysis of 10 efflux pump genes in multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis clinical isolates. J Glob Antimicrob Resist 17:201\u2013208","journal-title":"J Glob Antimicrob Resist"},{"key":"4314_CR37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jgar.2019.01.003","volume":"17","author":"J Kardan-Yamchi","year":"2019","unstructured":"Kardan-Yamchi J, Kazemian H, Haeili M, Harati AA, Amini S, Feizabadi MM (2019b) Expression analysis of 10 efflux pump genes in multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis clinical isolates. J Global Antimicrob Resist 17:201\u2013208","journal-title":"J Global Antimicrob Resist"},{"issue":"2","key":"4314_CR1","first-page":"63","volume":"15","author":"OO Komolafe","year":"2003","unstructured":"Komolafe OO (2003) Antibiotic resistance in bacteria - an emerging public health problem. Malawi Med J 15(2):63\u201367","journal-title":"Malawi Med J"},{"issue":"1","key":"4314_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.tim.2021.05.001","volume":"30","author":"M Laws","year":"2022","unstructured":"Laws M, Jin P, Rahman KM (2022) Efflux pumps in Mycobacterium tuberculosis and their Inhibition to tackle antimicrobial resistance. Trends Microbiol 30(1):57\u201368","journal-title":"Trends Microbiol"},{"issue":"1","key":"4314_CR20","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1128\/AAC.01998-15","volume":"60","author":"JK Lee","year":"2016","unstructured":"Lee JK, Seo CH, Luchian T, Park Y (2016) Antimicrobial peptide CMA3 derived from the CA-MA hybrid peptide: antibacterial and Anti-inflammatory activities with low cytotoxicity and mechanism of action in Escherichia coli. Antimicrob Agents Chemother 60(1):495\u2013506","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"4314_CR24","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1128\/JCM.02083-07","volume":"46","author":"B Leonard","year":"2008","unstructured":"Leonard B, Coronel J, Siedner M, Grandjean L, Caviedes L, Navarro P et al (2008) Inter- and intra-assay reproducibility of microplate Alamar blue assay results for Isoniazid, rifampicin, ethambutol, streptomycin, Ciprofloxacin, and capreomycin drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 46(10):3526\u20133529","journal-title":"J Clin Microbiol"},{"issue":"2","key":"4314_CR16","doi-asserted-by":"publisher","first-page":"e0119013","DOI":"10.1371\/journal.pone.0119013","volume":"10","author":"G Li","year":"2015","unstructured":"Li G, Zhang J, Guo Q, Jiang Y, Wei J, Zhao LL et al (2015) Efflux pump gene expression in multidrug-resistant Mycobacterium tuberculosis clinical isolates. PLoS ONE 10(2):e0119013","journal-title":"PLoS ONE"},{"issue":"4","key":"4314_CR25","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta delta C(T)) method. Methods 25(4):402\u2013408","journal-title":"Methods"},{"issue":"7","key":"4314_CR39","doi-asserted-by":"publisher","first-page":"e3175","DOI":"10.1002\/psc.3175","volume":"25","author":"H Madanchi","year":"2019","unstructured":"Madanchi H, Khalaj V, Jang S, Shabani AA, Ebrahimi Kiasari R, Seyed Mousavi SJ et al (2019) AurH1: a new heptapeptide derived from Aurein1.2 antimicrobial peptide with specific and exclusive fungicidal activity. J Pept Sci 25(7):e3175","journal-title":"J Pept Sci"},{"issue":"2","key":"4314_CR19","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/cbdd.13689","volume":"96","author":"H Madanchi","year":"2020","unstructured":"Madanchi H, Sardari S, Shajiee H, Taherian S, Ashkar M, Johari B et al (2020a) Design of new truncated derivatives based on direct and reverse mirror repeats of first six residues of Caerin 4 antimicrobial peptide and evaluation of their activity and cytotoxicity. Chem Biol Drug Des 96(2):801\u2013811","journal-title":"Chem Biol Drug Des"},{"issue":"4","key":"4314_CR26","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1007\/s12602-020-09648-5","volume":"12","author":"H Madanchi","year":"2020","unstructured":"Madanchi H, Ebrahimi Kiasari R, Seyed Mousavi SJ, Johari B, Shabani AA, Sardari S (2020b) Design and synthesis of Lipopolysaccharide-Binding antimicrobial peptides based on truncated rabbit and human CAP18 peptides and evaluation of their action mechanism. Probiotics Antimicrob Proteins 12(4):1582\u20131593","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"4","key":"4314_CR38","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.micres.2009.04.002","volume":"165","author":"S Malla","year":"2010","unstructured":"Malla S, Niraula NP, Liou K, Sohng JK (2010) Self-resistance mechanism in streptomyces Peucetius: overexpression of DrrA, DrrB and DrrC for doxorubicin enhancement. Microbiol Res 165(4):259\u2013267","journal-title":"Microbiol Res"},{"issue":"null","key":"4314_CR14","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.2147\/IDR.S255889","volume":"13","author":"N Mansoori","year":"2020","unstructured":"Mansoori N, Vaziri F, Amini S, Khanipour S, Pourazar Dizaji S, Douraghi M (2020) Spoligotype and drug susceptibility profiles of Mycobacterium tuberculosis complex isolates in Golestan Province, North Iran. Infect Drug Resist 13(null):2073\u20132081","journal-title":"Infect Drug Resist"},{"issue":"1","key":"4314_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12962-023-00479-z","volume":"21","author":"M Meskini","year":"2023","unstructured":"Meskini M, Madadi N, Ahmadi K, Vaziri F, Fateh A, Siadat SD (2023) Tuberculosis prevention, diagnosis, and treatment financial profile during 2006\u20132021: PART A. Cost Eff Resource Allocation 21(1):68","journal-title":"Cost Eff Resource Allocation"},{"issue":"10","key":"4314_CR4","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/s41570-021-00313-1","volume":"5","author":"M Miethke","year":"2021","unstructured":"Miethke M, Pieroni M, Weber T, Br\u00f6nstrup M, Hammann P, Halby L et al (2021) Towards the sustainable discovery and development of new antibiotics. Nat Reviews Chem 5(10):726\u2013749","journal-title":"Nat Reviews Chem"},{"issue":"4","key":"4314_CR22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s10989-022-10433-x","volume":"28","author":"S Namvar Arabani","year":"2022","unstructured":"Namvar Arabani S, Madanchi H, Ajoudanifar H, Shabani AA (2022) Evaluation of antibacterial, antifungal, and cytotoxicity effects of CecropinA-Magenin2 (CE-MA) peptide and its truncated derivatives and study of their action mechanism. Int J Pept Res Ther 28(4):126","journal-title":"Int J Pept Res Ther"},{"key":"4314_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbrc.2021.02.106","volume":"549","author":"S Namvar Erbani","year":"2021","unstructured":"Namvar Erbani S, Madanchi H, Ajodani Far H, Rostamian M, Rahmati S, Shabani AA (2021) First report of antifungal activity of CecropinA-Magenin2 (CE-MA) hybrid peptide and its truncated derivatives. Biochem Biophys Res Commun 549:157\u2013163","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"4314_CR35","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4103\/ijmy.ijmy_26_17","volume":"6","author":"A Narang","year":"2017","unstructured":"Narang A, Giri A, Gupta S, Garima K, Bose M, Varma-Basil M (2017) Contribution of putative efflux pump genes to Isoniazid resistance in clinical isolates of Mycobacterium tuberculosis. Int J Mycobacteriol 6(2):177\u2013183","journal-title":"Int J Mycobacteriol"},{"issue":"9","key":"4314_CR33","doi-asserted-by":"publisher","first-page":"e0223163","DOI":"10.1371\/journal.pone.0223163","volume":"14","author":"A Narang","year":"2019","unstructured":"Narang A, Garima K, Porwal S, Bhandekar A, Shrivastava K, Giri A et al (2019) Potential impact of efflux pump genes in mediating rifampicin resistance in clinical isolates of Mycobacterium tuberculosis from India. PLoS ONE 14(9):e0223163","journal-title":"PLoS ONE"},{"key":"4314_CR18","doi-asserted-by":"crossref","unstructured":"Nishino K, Yamasaki S, Nakashima R, Zwama M, Hayashi-Nishino M (2021) Function and inhibitory mechanisms of multidrug efflux pumps. Front Microbiol.;12","DOI":"10.3389\/fmicb.2021.737288"},{"key":"4314_CR27","unstructured":"Organisation WH (2023) Global tuberculosis report 2023. Geneva: World Health Organization; Licence: CC BY-NC-SA 3.0 IGO. https:\/\/doi.org\/wwwwhoint\/publications\/i\/item\/97892400838512023"},{"key":"4314_CR23","volume-title":"Updated interim critical concentrations for first-line and second-line DST (as of May 2012)","author":"W Organization","year":"2012","unstructured":"Organization W (2012) Updated interim critical concentrations for first-line and second-line DST (as of May 2012). World Health Organization, Geneva"},{"key":"4314_CR13","unstructured":"Organization WH (2013) Global tuberculosis report 2013. World Health Organization"},{"issue":"10","key":"4314_CR32","doi-asserted-by":"publisher","first-page":"e1001067","DOI":"10.1371\/journal.ppat.1001067","volume":"6","author":"BM Peters","year":"2010","unstructured":"Peters BM, Shirtliff ME, Jabra-Rizk MA (2010) Antimicrobial peptides: primeval molecules or future drugs? PLoS Pathog 6(10):e1001067","journal-title":"PLoS Pathog"},{"issue":"1","key":"4314_CR11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41467-023-36282-w","volume":"14","author":"J Phelan","year":"2023","unstructured":"Phelan J, Gomez-Gonzalez PJ, Andreu N, Omae Y, Toyo-Oka L, Yanai H et al (2023) Genome-wide host-pathogen analyses reveal genetic interaction points in tuberculosis disease. Nat Commun 14(1):549","journal-title":"Nat Commun"},{"issue":"2","key":"4314_CR36","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1128\/AAC.01482-12","volume":"57","author":"L Rodrigues","year":"2013","unstructured":"Rodrigues L, Villellas C, Bailo R, Viveiros M, A\u00ednsa JA (2013) Role of the Mmr efflux pump in drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 57(2):751\u2013757","journal-title":"Antimicrob Agents Chemother"},{"key":"4314_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.coph.2014.09.006","volume":"18","author":"GM Rossolini","year":"2014","unstructured":"Rossolini GM, Arena F, Pecile P, Pollini S (2014) Update on the antibiotic resistance crisis. Curr Opin Pharmacol 18:56\u201360","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"4314_CR5","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/s42003-022-03899-4","volume":"5","author":"J Shi","year":"2022","unstructured":"Shi J, Chen C, Wang D, Wang Z, Liu Y (2022) The antimicrobial peptide LI14 combats multidrug-resistant bacterial infections. Commun Biology 5(1):926","journal-title":"Commun Biology"},{"issue":"4","key":"4314_CR3","first-page":"277","volume":"40","author":"CL Ventola","year":"2015","unstructured":"Ventola CL (2015) The antibiotic resistance crisis: part 1: causes and threats. P T 40(4):277\u2013283","journal-title":"P T"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-025-04314-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-025-04314-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-025-04314-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T04:02:37Z","timestamp":1745899357000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-025-04314-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["4314"],"URL":"https:\/\/doi.org\/10.1007\/s00203-025-04314-2","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"8 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"111"}}